Animal Testing Alternatives Need Central Office At US FDA, Science Board

To better handle the growth of technologies intended to reduce the need for animal testing for regulatory decisions, a US Food and Drug Administration Science Board subcommittee suggests the agency establish a central office to oversee so-called new alternative methods (NAMs) in the commissioner’s office.

The New Alternative Methods Subcommittee presented its recommendations at the Science Board’s 7 October meeting, a year after the commissioner’s office asked the panel to investigate spurring adoption...